Cargando…
Fabry disease: a survey of visual and ocular symptoms
PURPOSE: To evaluate a visual symptoms survey on patients with a known diagnosis of Fabry disease, and to compare the scores to those from a group of healthy subjects. MATERIALS AND METHODS: An ocular symptom survey instrument was used to evaluate the symptoms of general ocular problems like itching...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145731/ https://www.ncbi.nlm.nih.gov/pubmed/25170250 http://dx.doi.org/10.2147/OPTH.S66748 |
_version_ | 1782332219572879360 |
---|---|
author | Davey, Pinakin Gunvant |
author_facet | Davey, Pinakin Gunvant |
author_sort | Davey, Pinakin Gunvant |
collection | PubMed |
description | PURPOSE: To evaluate a visual symptoms survey on patients with a known diagnosis of Fabry disease, and to compare the scores to those from a group of healthy subjects. MATERIALS AND METHODS: An ocular symptom survey instrument was used to evaluate the symptoms of general ocular problems like itching, tearing, dryness, burning sensation, sensation of foreign body, difficulty in scotopic and photopic vision, and asthenopic symptoms. The survey instrument was administered to 95 participants (75 patients with Fabry disease and 20 healthy controls; median age: 32.5 years [standard deviation: 19.1 years] and 42.6 years [standard deviation: 14.7 years], respectively). A Mann–Whitney test was performed to evaluate the difference between the Fabry group and the healthy controls for each symptom survey severity score. A P-value <0.05 was considered significant. RESULTS: Of the survey instrument items, it was found that compared to the control group, the mean severity score of the Fabry disease group was significant for “dryness” of the eyes (P=0.02), “blurry/dim vision” (P=0.02), “hard to see in dark places” (P=0.01), and “halos around light” (P=0.01). The Fabry group also had a mean severity score for “soreness/tiredness” that was significantly higher than that of the control group (P=0.009). CONCLUSION: The patients with Fabry disease may be suffering from ocular and visual symptoms related to manifestations of the disease. Further quantitative testing is needed to investigate the ocular and visual symptoms. |
format | Online Article Text |
id | pubmed-4145731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-41457312014-08-28 Fabry disease: a survey of visual and ocular symptoms Davey, Pinakin Gunvant Clin Ophthalmol Original Research PURPOSE: To evaluate a visual symptoms survey on patients with a known diagnosis of Fabry disease, and to compare the scores to those from a group of healthy subjects. MATERIALS AND METHODS: An ocular symptom survey instrument was used to evaluate the symptoms of general ocular problems like itching, tearing, dryness, burning sensation, sensation of foreign body, difficulty in scotopic and photopic vision, and asthenopic symptoms. The survey instrument was administered to 95 participants (75 patients with Fabry disease and 20 healthy controls; median age: 32.5 years [standard deviation: 19.1 years] and 42.6 years [standard deviation: 14.7 years], respectively). A Mann–Whitney test was performed to evaluate the difference between the Fabry group and the healthy controls for each symptom survey severity score. A P-value <0.05 was considered significant. RESULTS: Of the survey instrument items, it was found that compared to the control group, the mean severity score of the Fabry disease group was significant for “dryness” of the eyes (P=0.02), “blurry/dim vision” (P=0.02), “hard to see in dark places” (P=0.01), and “halos around light” (P=0.01). The Fabry group also had a mean severity score for “soreness/tiredness” that was significantly higher than that of the control group (P=0.009). CONCLUSION: The patients with Fabry disease may be suffering from ocular and visual symptoms related to manifestations of the disease. Further quantitative testing is needed to investigate the ocular and visual symptoms. Dove Medical Press 2014-08-19 /pmc/articles/PMC4145731/ /pubmed/25170250 http://dx.doi.org/10.2147/OPTH.S66748 Text en © 2014 Davey. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Davey, Pinakin Gunvant Fabry disease: a survey of visual and ocular symptoms |
title | Fabry disease: a survey of visual and ocular symptoms |
title_full | Fabry disease: a survey of visual and ocular symptoms |
title_fullStr | Fabry disease: a survey of visual and ocular symptoms |
title_full_unstemmed | Fabry disease: a survey of visual and ocular symptoms |
title_short | Fabry disease: a survey of visual and ocular symptoms |
title_sort | fabry disease: a survey of visual and ocular symptoms |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145731/ https://www.ncbi.nlm.nih.gov/pubmed/25170250 http://dx.doi.org/10.2147/OPTH.S66748 |
work_keys_str_mv | AT daveypinakingunvant fabrydiseaseasurveyofvisualandocularsymptoms |